nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP1—systemic scleroderma	0.671	1	CbGaD
Doxycycline—SLC22A6—Captopril—systemic scleroderma	0.0499	0.342	CbGbCtD
Doxycycline—SLC22A11—Methotrexate—systemic scleroderma	0.0389	0.266	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—systemic scleroderma	0.0226	0.155	CbGbCtD
Doxycycline—MMP13—skeletal joint—systemic scleroderma	0.0169	0.196	CbGeAlD
Doxycycline—SLC22A6—Methotrexate—systemic scleroderma	0.0158	0.108	CbGbCtD
Doxycycline—MMP1—dermis—systemic scleroderma	0.0138	0.16	CbGeAlD
Doxycycline—MMP1—skeletal joint—systemic scleroderma	0.0119	0.138	CbGeAlD
Doxycycline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0105	0.0718	CbGbCtD
Doxycycline—CYP3A4—Prednisone—systemic scleroderma	0.00839	0.0574	CbGbCtD
Doxycycline—MMP1—artery—systemic scleroderma	0.00498	0.0578	CbGeAlD
Doxycycline—MMP1—endothelium—systemic scleroderma	0.00421	0.0488	CbGeAlD
Doxycycline—MMP1—blood vessel—systemic scleroderma	0.00388	0.045	CbGeAlD
Doxycycline—MMP13—connective tissue—systemic scleroderma	0.00283	0.0328	CbGeAlD
Doxycycline—MMP8—connective tissue—systemic scleroderma	0.00255	0.0296	CbGeAlD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—COL1A2—systemic scleroderma	0.00228	0.0242	CbGpPWpGaD
Doxycycline—MMP7—connective tissue—systemic scleroderma	0.00225	0.0262	CbGeAlD
Doxycycline—MMP13—digestive system—systemic scleroderma	0.00204	0.0237	CbGeAlD
Doxycycline—MMP1—connective tissue—systemic scleroderma	0.00199	0.0231	CbGeAlD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGAM—systemic scleroderma	0.00198	0.021	CbGpPWpGaD
Doxycycline—MMP13—tendon—systemic scleroderma	0.00194	0.0226	CbGeAlD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.00186	0.0198	CbGpPWpGaD
Doxycycline—MMP8—digestive system—systemic scleroderma	0.00184	0.0214	CbGeAlD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—COL1A2—systemic scleroderma	0.00183	0.0195	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—COL1A2—systemic scleroderma	0.00182	0.0193	CbGpPWpGaD
Doxycycline—MMP1—smooth muscle tissue—systemic scleroderma	0.00182	0.0211	CbGeAlD
Doxycycline—MMP1—skin of body—systemic scleroderma	0.0018	0.0209	CbGeAlD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP1—systemic scleroderma	0.00178	0.0189	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—COL1A2—systemic scleroderma	0.00177	0.0188	CbGpPWpGaD
Doxycycline—MMP13—lung—systemic scleroderma	0.00171	0.0198	CbGeAlD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP1—systemic scleroderma	0.00169	0.0179	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—HSPG2—systemic scleroderma	0.00164	0.0174	CbGpPWpGaD
Doxycycline—MMP7—digestive system—systemic scleroderma	0.00163	0.0189	CbGeAlD
Doxycycline—Minocycline—IL1B—systemic scleroderma	0.00158	0.586	CrCbGaD
Doxycycline—MMP8—lung—systemic scleroderma	0.00154	0.0179	CbGeAlD
Doxycycline—MMP7—p75(NTR)-mediated signaling—RHOB—systemic scleroderma	0.0015	0.0159	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP1—systemic scleroderma	0.00147	0.0156	CbGpPWpGaD
Doxycycline—MMP1—digestive system—systemic scleroderma	0.00144	0.0167	CbGeAlD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.00137	0.0146	CbGpPWpGaD
Doxycycline—MMP1—tendon—systemic scleroderma	0.00137	0.0159	CbGeAlD
Doxycycline—MMP7—lung—systemic scleroderma	0.00136	0.0158	CbGeAlD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP2—systemic scleroderma	0.00131	0.0139	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP1—systemic scleroderma	0.0013	0.0138	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP1—systemic scleroderma	0.00125	0.0133	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—COL1A2—systemic scleroderma	0.00125	0.0133	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP1—systemic scleroderma	0.00123	0.0131	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—COL1A2—systemic scleroderma	0.00121	0.0129	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—COL1A2—systemic scleroderma	0.00121	0.0128	CbGpPWpGaD
Doxycycline—MMP1—lung—systemic scleroderma	0.0012	0.0139	CbGeAlD
Doxycycline—MMP13—Degradation of the extracellular matrix—HSPG2—systemic scleroderma	0.00119	0.0127	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP1—systemic scleroderma	0.00119	0.0126	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—HSPG2—systemic scleroderma	0.00115	0.0122	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP2—systemic scleroderma	0.00114	0.0121	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—COL1A2—systemic scleroderma	0.00112	0.0119	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—systemic scleroderma	0.00111	0.414	CrCbGaD
Doxycycline—MMP13—Collagen degradation—MMP1—systemic scleroderma	0.00107	0.0114	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP1—systemic scleroderma	0.00104	0.011	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP1—systemic scleroderma	0.00104	0.011	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.00103	0.011	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—MMP2—systemic scleroderma	0.00103	0.0109	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.001	0.0107	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000981	0.0104	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—FBN1—systemic scleroderma	0.00098	0.0104	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000969	0.0103	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SELP—systemic scleroderma	0.000961	0.0102	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000952	0.0101	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SMAD7—systemic scleroderma	0.000921	0.00979	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—HSPG2—systemic scleroderma	0.000921	0.00979	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP2—systemic scleroderma	0.00092	0.00977	CbGpPWpGaD
Doxycycline—SLC22A11—digestive system—systemic scleroderma	0.000911	0.0106	CbGeAlD
Doxycycline—MMP8—Collagen degradation—MMP9—systemic scleroderma	0.000855	0.00909	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL13—systemic scleroderma	0.000842	0.00894	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP2—systemic scleroderma	0.00083	0.00882	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000827	0.00879	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP2—systemic scleroderma	0.000802	0.00852	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000774	0.00823	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—ITGAM—systemic scleroderma	0.000768	0.00816	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000754	0.00801	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP1—systemic scleroderma	0.000744	0.00791	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000735	0.00781	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000728	0.00773	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000716	0.0076	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—FBN1—systemic scleroderma	0.000715	0.00759	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MMP1—systemic scleroderma	0.000698	0.00742	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000691	0.00734	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—FBN1—systemic scleroderma	0.00069	0.00733	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000688	0.00731	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000685	0.00728	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000685	0.00728	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—COL1A2—systemic scleroderma	0.000672	0.00714	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—EDN1—systemic scleroderma	0.000658	0.00699	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000655	0.00696	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP2—systemic scleroderma	0.000641	0.00681	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—systemic scleroderma	0.000624	0.00663	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000622	0.00661	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.000613	0.00652	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000604	0.00642	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—systemic scleroderma	0.000603	0.0064	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—systemic scleroderma	0.000603	0.0064	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000582	0.00618	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—systemic scleroderma	0.000576	0.00612	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—systemic scleroderma	0.000576	0.00612	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CCL2—systemic scleroderma	0.000568	0.00603	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000553	0.00587	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—FBN1—systemic scleroderma	0.000552	0.00586	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP1—systemic scleroderma	0.000543	0.00577	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000534	0.00567	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP1—systemic scleroderma	0.000524	0.00557	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000515	0.00548	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—systemic scleroderma	0.0005	0.00531	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—HSPG2—systemic scleroderma	0.0005	0.00531	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—COL1A2—systemic scleroderma	0.0005	0.00531	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—systemic scleroderma	0.000497	0.00528	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000492	0.00523	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—systemic scleroderma	0.000485	0.00516	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000483	0.00513	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000483	0.00513	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000483	0.00513	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—systemic scleroderma	0.000482	0.00512	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—systemic scleroderma	0.000482	0.00512	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic scleroderma	0.000475	0.00504	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—systemic scleroderma	0.000469	0.00498	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000454	0.00482	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000438	0.00466	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CCL2—systemic scleroderma	0.000438	0.00466	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—systemic scleroderma	0.000433	0.0046	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—systemic scleroderma	0.00042	0.00446	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000413	0.00439	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—systemic scleroderma	0.000411	0.00437	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—systemic scleroderma	0.000406	0.00431	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000401	0.00426	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—systemic scleroderma	0.000397	0.00422	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000387	0.00412	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000386	0.0041	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000386	0.0041	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000351	0.00372	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—systemic scleroderma	0.000339	0.0036	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—systemic scleroderma	0.000331	0.00351	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—systemic scleroderma	0.000324	0.00345	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—systemic scleroderma	0.000319	0.00339	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—systemic scleroderma	0.000316	0.00335	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP1—systemic scleroderma	0.000312	0.00331	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—systemic scleroderma	0.000305	0.00324	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000295	0.00314	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SELP—systemic scleroderma	0.000261	0.00277	CbGpPWpGaD
Doxycycline—CYP3A4—digestive system—systemic scleroderma	0.000255	0.00296	CbGeAlD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—systemic scleroderma	0.000244	0.00259	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000244	0.00259	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RHOB—systemic scleroderma	0.000243	0.00258	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—systemic scleroderma	0.000241	0.00256	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP1—systemic scleroderma	0.000228	0.00242	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CSK—systemic scleroderma	0.000222	0.00235	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP1—systemic scleroderma	0.00022	0.00233	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ITGAM—systemic scleroderma	0.000208	0.00221	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—systemic scleroderma	0.000181	0.00193	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—systemic scleroderma	0.000176	0.00187	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—systemic scleroderma	0.00017	0.00181	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—systemic scleroderma	0.000149	0.00159	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	0.000147	0.00156	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—systemic scleroderma	0.000136	0.00144	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—systemic scleroderma	0.000132	0.00141	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—systemic scleroderma	0.000128	0.00136	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—systemic scleroderma	0.000128	0.00136	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—systemic scleroderma	0.000109	0.00116	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—systemic scleroderma	0.000105	0.00112	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—systemic scleroderma	0.000102	0.00109	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—systemic scleroderma	8.42e-05	0.000895	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—systemic scleroderma	7.57e-05	0.000804	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCL2—systemic scleroderma	6.68e-05	0.00071	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—systemic scleroderma	6.35e-05	0.000675	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—systemic scleroderma	5e-05	0.000532	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HSPG2—systemic scleroderma	9.73e-06	0.000103	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CTGF—systemic scleroderma	7.37e-06	7.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—systemic scleroderma	3.21e-06	3.41e-05	CbGpPWpGaD
